Chemopreventive Agent Repository/Chemistry Support
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N91023R00001
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute seeks to continue centralized chemopreventive agent repository and chemistry support services through an indefinite-delivery, indefinite-quantity contract with a period of performance from July 2023 through June 2028. Offerors must submit proposals by February 28, 2023 to provide logistic organization for agent acquisition, tracking, storage, testing, quality control, and distribution to support the Division of Cancer Prevention's research program. Proposals will be evaluated based on technical approach, past performance, and price. The contract value is estimated between $1,000,000 to $49,990,000.
There is no set-aside designation. The NAICS code is 541715 and PSC code is R425. The incumbent contractor is expected to transfer inventory and provide transition assistance. The contractor will maintain storage facilities and procure agents to support an estimated 200 studies annually over the five year base period and one option year, with performance taking place at the contractor's location. The first amendment clarifies budget and transition requirements while the second provides answers to questions from potential offerors.
Notice text
2 versions
Update #2 · Latest ·
1) Responses to submitted questions are attached.
2) Solicitation due date and time are NOT changed as a result of this amendment.
Update #1 ·
The Division of Cancer Prevention (DCP), NCI, has a long-standing pharmaceutical agent development program administered through the Chemopreventive Agent Development and Research Group (CADRG) as a Repository services unit. The object of the Repository program is to establish a centralized source of agents for use in studies by the DCP and to support the translation of promising laboratory discoveries into effective interventions for the prevention or reduction of cancer.
Files
| File | Type | Posted |
|---|---|---|
| 75N91023R00001_Amendment_0001_0001.pdf | ||
| Sol_75N91023R00001_Amd_0001.pdf | ||
| RFP_75N91023R00001_FINAL_w_attachments.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Centralized Chemopreventive Agent Repository and Chemistry Support Services | Award Notice | |
| This notice | Solicitation | |
| Centralized Chemopreventive Agent Repository and Chemistry Support | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research” | National Cancer Institute | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity